Sin G. Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 219 publications
Serum ketone body levels and risk of incident kidney and cardiovascular events among patients with type 2 diabetes: a prospective cohort study.
Journal: Diabetes research and clinical practice
Published: June 04, 2026
Decision Tree Prediction of Saline Infusion Test Outcomes in Suspected Primary Aldosteronism: A Multicenter CDM Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 24, 2026
Circulating GDF15 levels reflect metabolic and inflammatory burden in early dysglycemia: findings from the ADIOS cohort.
Journal: Diabetes research and clinical practice
Published: April 09, 2026
The effect of rapid improvement of blood glucose level on diabetic neuropathy in Korean people with diabetes mellitus.
Journal: Diabetes research and clinical practice
Published: March 30, 2026
Persistent and emerging cancer risks after migration: Evidence from North and South Korean cohorts.
Journal: Journal of internal medicine
Published: March 11, 2026
Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial.
Journal: Diabetes, obesity & metabolism
Published: December 16, 2025
Correction: Malignancy risk in AUS thyroid lesions: comparison between FNA and CNB with implications for NIFTP diagnosis.
Journal: Frontiers in endocrinology
Published: November 25, 2025
Resting-State Functional Connectivity Changes Associated With Post-Traumatic Stress and Anxiety Symptoms in North Korean Refugees.
Journal: Psychiatry investigation
Published: October 24, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial.
Journal: Diabetes, obesity & metabolism
Published: October 21, 2025
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial.
Journal: Lancet (London, England)
Published: September 10, 2025
Malignancy risk in AUS thyroid lesions: comparison between FNA and CNB with implications for NIFTP diagnosis.
Journal: Frontiers in endocrinology
Published: August 25, 2025
Understanding thyroid cancer-specific mortality metrics: a response to recent commentary.
Journal: International journal of surgery (London, England)
Published: July 25, 2025
Last Updated: 09/26/2026